Patent ID: 7867517

Claim:
Oral prompt-release pharmaceutical composition for the improved oral absorption of active ingredients, consisting essentially of: a) active ingredient; b) a macrogolglyceride matrix in combination with diethylene glycol monoethyl ether or polyethylene glycol hydroxystearate, forming a eutectic mixture melting at 35-37° C., in which the active ingredient is at least partially soluble and/or dispersed and/or embedded or granulated with said macrogolglycerides previously solubilized or suspended in solvent; c) a surface acting component selected from phosphatidyl choline, lecithin, poloxamer, sodium lauryl sulfate, sodium sulfosuccinate, or sodium dodecyl sulfate; d) cyclodextrin and/or superdisintegrant, that is dispersed in or is loaded on the matrix, to obtain a liquid, semisolid or solid form, wherein the superdisintegrant is selected from sodium starch glycolate, croscarmellose sodium, Amberlite or cross-linked polyvinylpyrrolidone; and e) optionally one or more excipients selected from silica, celluloses, starches, sugars, polyvinyl pyrrolidones, methacrylates, glidants, antiaggregants, lubricants, magnesium stearate, stearic acid, and talc, wherein said composition displays prompt-release of the active ingredient.